Larvol Delta - Adicet-Presents-Preclinical-Data-at-the-ISCT-Annual-Meeting-Highlighting-Potential-Advantages-of-the-NonGeneEdited-Approach-for-its-Investigational-Allogeneic-Gamma-Delta-CAR-T-Cell-Therapy-Targeting-CD20-for-B-Cell-Malignancies

ADI-001 - Adicet Bio

https://www.businesswire.com/news/home/20220505005373/en/Adicet-Presents-Preclinical-Data-at-the-ISCT-Annual-Meeting-Highlighting-Potential-Advantages-of-the-Non-Gene-Edited-Approach-for-its-Investigational-Allogeneic-Gamma-Delta-CAR-T-Cell-Therapy-Targeting-CD20-for-B-Cell-Malignancies

May 5, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next